Effects of tumor necrosis factor-alpha on the 26S proteasome and 19S regulator in skeletal muscle of severely scalded mice

Journal of Burn Care and Research

Volumn 27, Issue 2, 2006, Pages 226-233

  Tan, Yinling ^a   Peng, Xi ^a   Wang, Fengjun ^a   You, Zhongyi ^a   Dong, Yanling ^b   Wang, Shiliang ^a  

^a SOUTHWEST HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEASOME; TUMOR NECROSIS FACTOR ALPHA; 26S PROTEASOME NON ATPASE REGULATORY SUBUNIT 13; 26S PROTEASOME NON-ATPASE REGULATORY SUBUNIT 13; ADENOSINE TRIPHOSPHATASE; ATP DEPENDENT 26S PROTEASE; MESSENGER RNA; MUSCLE PROTEIN; PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL METABOLIC RATE; BURN; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; MOUSE; MUSCLE ATROPHY; MUSCLE INJURY; NITROGEN BALANCE; NONHUMAN; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCALD; SKELETAL MUSCLE; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; ENZYMOLOGY; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BURNS; ENDOPEPTIDASES; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED BALB C; MUSCLE PROTEINS; MUSCLE, SKELETAL; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745346649     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/01.BCR.0000203378.85736.38     Document Type: Article

References (25)

1. Hasselgren PO, Fischer JE. Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann Surg 2001;233:9-17.
2. Bochtler M, Ditzel L, Groll M, Hartmann C, Huber R. The proteasome. Annu Rev Biophys Biomol Struct 1999;28:295-317.
3. Jagoe RT, Goldberg AL. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care 2001;4:183-90.
4. Cannon JG, Friedberg JS, Gelfand JA, Tompkins RG, Burke JF, Dinarello CA. Circulating interleukin-1 beta and tumor necrosis factor-alpha concentrations after burn injury in humans. Crit Care Med 1992;20:1414-9.
5. Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, Argiles JM. TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun 199713;230:238-41.
6. Garcia-Martinez C, Llovera M, Agell N, Lopez-Soriano FJ, Argiles J-M. Ubiquitin gene expression in skeletal muscle is increased during sepsis: involvement of TNF-alpha but not IL-1. Biochem Biophys Res Commun. 199526;217:839-44.
7. Flores EA, Bistrian BR. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. J Clin Invest 1989;83:1614-42.
8. Tamura T, Tanaka K, Tanahashi N, Ichihara A. Improved method for preparation of ubiquitin-ligated lysozyme as substrate of ATP-dependent proteolysis. FEBS Lett 1991;292:154-8.
9. Matthews W, Driscoll J, Tanaka k, Ichihara A, Goldberg A-L. Involvement of the proteasome in various degradative processes in mammalian cells. Proc Natl Acad Sci USA 1989;86:2597-601.
10. Chai J, Wu Y, Sheng Z. The relationship between skeletal muscle proteolysis and ubiquitin-proteasome proteolytic pathway in burned rats. Burns 2002;28:527-33.
11. Fang CH, Li BG, Wray CJ, Hasselgren PO. Insulin-like growth factor-I inhibits lysosomal and proteasome-dependent proteolysis in skeletal muscle after burn injury. J Burn Care Rehabil 2002;23:318-25.
12. Fang CH, Li BG, Fischer DR, et al. Burn injury upregulates the activity and gene expression of the 20 S proteasome in rat skeletal muscle. Clin Sci (Lond) 2000;99:181-7.
13. Fang CH, Sun X, Li BG, et al. Burn injuries in rats upregulate the gene expression of the ubiquitin-conjugating enzyme E2(14k) in skeletal muscle. J Burn Care Rehabil 2000;21:528-34.
14. Starnes HF, Warren RS. Redistribution of amino acids in rat liver and muscle induced by tumor necrosis factor requires the adrenal response. Surg Forum 1987;18:41-5.
15. Llovera M, Garcia MC, Lopez SJ, et al. Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1. Cancer Lett 1998.;130:19-27.
16. Garcia C, Agell N, Llovera M, et al. TNF-α increases the ubiquitinazation of rat skeletal muscle proteins. FEBS 1998;323:211-4.
17. Llovera M, Carbo N, Garcia-Martinez C, et al. Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats. Biochem Biophys Res Commun 1996;221:653-5.
18. Combaret L, Cecile R. Manipulation of the ubiquitin-proteasome in cachexia:pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats. Mol Biol Rep 1999;26:95-101.
19. Costelli P, Bossola M, Muscaritoli M, et al. Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats. Cytokine 2002;19:1-5.
20. Hu X, Bryington M, Fisher AB, et al. Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest. J Biol Chem 2002;277:16528-37.
21. Sakai T, Kambe F, Mitsuyama H, et al. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors. J Bone Miner Res 2001;16:1272-80.
22. Kim HH, Kim K. Enhancement of TNF-alpha-mediated cell death in vascular smooth muscle cells through cytochrome c-independent pathway by the proteasome inhibitor. FEBS Lett 2003;535:190-4.
23. Botion LM, Brasier AR, Tian B, Udupi V, Green A. Inhibition of proteasome activity blocks the ability of TNF alpha to down-regulate G(i) proteins and stimulate lipolysis. Endocrinology 2001;142:5069-75.
24. Pallares-Trujillo J, Carbo N, Lopez-Soriano FJ, Argiles JM. Does the mechanism responsible for TNF-mediated insulin resistance involve the proteasome? Med Hypotheses 2000;54:565-9.
25. Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G. The tumour suppressor CYLD negatively regulates NF-kappaB signaling by deubiquitination. Nature 2003;424:801-5.